Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2026 – November 2026 · 3 captures · latest observed messagingTransformative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseases
10 January 2026 · Transformative Therapies for Degenerative Diseases Affecting Longevityarchived page
6 October 2026 · Transformative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseasesarchived page
6 November 2026 · Transformative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseasescurrent websiteHistorical capture not publicly available
Seen September 2025 · 1 captureSIRONAX preview
Vitarelon, SIRONAX, Beijing Weitai Ruilong Biotechnology Co., Ltd. specializes in degenerative diseases, degenerative neurological diseases, Alzheimer's disease, and transformative therapies